Assessing the Value and Implications of Personalized/Precision Medicine and the "Lessons Learned" for Emerging Technologies: An Introduction

Value Health. 2017 Jan;20(1):30-31. doi: 10.1016/j.jval.2016.09.2405.

Author

Kathryn A Phillips¹

Affiliation

¹ Department of Clinical Pharmacy, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California, San Francisco, CA, USA; Philip R. Lee Institute for Health Policy, University of California, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.

PMID: 28212965
DOI: 10.1016/j.jval.2016.09.2405

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Biomedical Technology / economics
Biomedical Technology / methods*
Cost-Benefit Analysis / economics
Cost-Benefit Analysis / methods*
Humans
Precision Medicine / economics
Precision Medicine / methods*